Vertex Pharmaceuticals
VRTX
#200
Rank
โ‚ฌ94.55 B
Marketcap
371,73ย โ‚ฌ
Share price
-0.30%
Change (1 day)
-10.38%
Change (1 year)

Revenue for Vertex Pharmaceuticals (VRTX)

Revenue in 2025 (TTM): โ‚ฌ10.41 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ10.18 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ10.58 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vertex Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ10.21 B-3.53%
2024 โ‚ฌ10.58 B18.62%
2023 โ‚ฌ8.92 B7.23%
2022 โ‚ฌ8.32 B24.48%
2021 โ‚ฌ6.68 B32.56%
2020 โ‚ฌ5.04 B35.77%
2019 โ‚ฌ3.71 B39.49%
2018 โ‚ฌ2.66 B28.44%
2017 โ‚ฌ2.07 B28.17%
2016 โ‚ฌ1.61 B71.4%
2015 โ‚ฌ0.94 B97.84%
2014 โ‚ฌ0.47 B-45.62%
2013 โ‚ฌ0.87 B-23.98%
2012 โ‚ฌ1.15 B6.28%
2011 โ‚ฌ1.08 B907.75%
2010 โ‚ฌ0.10 B51.56%
2009 โ‚ฌ71.11 M-43.35%
2008 โ‚ฌ0.12 B-7.89%
2007 โ‚ฌ0.13 B-16.87%
2006 โ‚ฌ0.16 B20.73%
2005 โ‚ฌ0.13 B79.36%
2004 โ‚ฌ75.72 M43.12%
2003 โ‚ฌ52.9 M-65.67%
2002 โ‚ฌ0.15 B2.79%
2001 โ‚ฌ0.14 B79.36%
2000 โ‚ฌ83.57 M57.74%
1999 โ‚ฌ52.98 M55.24%
1998 โ‚ฌ34.12 M-7.53%
1997 โ‚ฌ36.91 M229.32%
1996 โ‚ฌ11.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ79.96 B 684.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.92 B 409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.99 B 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.19 B 441.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ40.91 B 301.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚ฌ55.46 M-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA